Waters Seminars

View Presentations

Monday, June 19th
12:45 PM – 1:45 PM

Modernizing, Managing, and Complying to Regulatory Advances in Science

This tutorial covers the strategy and business impacts of transferring liquid chromatography methods to new technologies, between laboratories, and even between companies when necessary. Specifically: what are the ‘rules’ that companies/laboratories must follow, how are they changing, and what does it mean? Waters will demonstrate solutions that have been developed to efficiently transfer methods while maintaining compliance in regulated laboratories. Throughout this presentation we will be using examples from actual situations, and discussing real-world troubleshooting tips to consider when difficulties are encountered. The process required to modernize and manage method transfers is often complex, and may benefit from an on-site consultation by Waters Professional Services in order to provide a tailored solution for your specific quality system.

Nigel Ewing
Product Marketing Manager
Waters Corporation, USA

A Ph.D graduate from Miami University, Ohio, USA, Nigel Ewing started his career as an applications scientist at Bruker Daltonics.  He went on to do research on heat shock proteins at Antigenics, a small pharmaceutical company focused on patient specific cancer therapies.  Prior to joining Waters, Nigel worked with Vertex pharmaceuticals in Boston for 10 years developing LCMS and LCMS/MS assays for DMPK including metabolite profiling, Pgp Permeability assays and small molecule chemical synthesis and purification.  Presently, Dr. Ewing is a Senior Product Marketing Manager where he focuses his extensive experience in mass spectrometry and chromatography in the Separations technology programs such as ACQUITY® Arc™ and the integrated microflow mass spectrometric turn-key solution ionKey®.

Wednesday, June 21st
12:45 PM – 1:45 PM

Successful Development and Implementation of Peptide Mapping and SEC-Based Protein Aggregate Determinations for Biotherapeutic Characterization

Peptide mapping and size-exclusion chromatography (SEC) are frequently used methods during the development and commercialization of biotherapeutics. Using relevant data, this technical seminar will review important principles and practices to achieve high-quality separations using columns specifically designed and QC tested to deliver reproducible results in validated methods.

Priya Jayaraman
Principal Product Manager
Waters Corporation, USA

Priya is a Principal Product Manager for Bioseparations columns at Waters, Inc. where she is focused on driving the development and commercialization of market-leading reagents and chromatography-based technologies for the separation, purification and characterization of biological molecules. Priya has over 10 years of experience in the bio-pharmaceutical industry supporting large molecule development across Research, Manufacturing, Process/Analytical Development and Program Management.

Stephan M. Koza
Research and Applied Sciences
Waters Corporation, USA

Stephan leads a research and applied science group at Waters that has a primary focus on the use of UPLC, HPLC, LC-MS, and sample preparation technologies for the analysis of biomolecules. Prior to joining Waters he had nearly twenty years of experience with Genetics Institute, Wyeth, and Pfizer where he was primarily involved with biopharmaceutical characterization and analytical method development.